Rewiring the Brain Through the Gut: Insights into Microbiota–Nervous System Interactions
Current Issues in Molecular Biology · 26.06.2025 · 47 (7) · 489
DOI: 10.3390/cimb47070489 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 26.06.2025. Verfasst von Ilinca Savulescu-Fiedler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 317 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The gut-brain axis (GBA) represents an operant acting in a two-direction communication system between the gastrointestinal tract and the central nervous system, mediated by the enteric nervous system (ENS), vagus nerve, immune pathways, and endocrine signaling. In recent years, evidence has highlighted the pivotal role of the gut microbiota in modulating this axis, forming the microbiota-gut-brain axis (MGBA). Our review synthesizes current knowledge on the anatomical and functional substrates of gut-brain communication, focusing on interoceptive signaling, the roles of intrinsic primary afferent neurons (IPANs) and enteroendocrine cells (EECs) and the influence of microbial metabolites, including short-chain fatty acids (SCFAs), bile acids, and indoles. These agents modulate neurotransmission, epithelial barrier function, and neuroimmune interactions. The vagus nerve serves as a primary pathway for afferent sensory signaling from the gut influenced indirectly by the ENS and microbiota. Dysbiosis has been associated with altered gut-brain signaling and implicated in the pathophysiology of disorders ranging from irritable bowel syndrome to mood disorders and neurodegeneration. Microbial modulation of host gene expression via epigenetic mechanisms, including microRNAs, adds another layer of complexity. The gut has a crucial role as an active sensory and signaling organ capable of influencing higher-order brain functions. Understanding the MGBA has significant implications for new therapeutic interventions targeting the microbiome to manage neurogastroenterological and even neuropsychiatric conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Department of Internal Medicine, Coltea Clinical Hospital, 030167 Bucharest, Romania.
- Department of Infectious Diseases, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- National Institute for Infectious Diseases "Prof. Dr. Matei Bals", 021105 Bucharest, Romania.
- Department of Physiology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Department of Dermatology, "Prof. N.C. Paulescu" National Institute of Diabetes, Nutrition and Metabolic Diseases, 011233 Bucharest, Romania.
ORCID-Profile: Constantin Căruntu, Corina Homentcovschi, Sandica Bucurica
Zitieren
APA
Savulescu-Fiedler, I., Benea, S. N., Căruntu, C., Nancoff, A. S., Homentcovschi, C., & Bucurica, S. (2025). Rewiring the Brain Through the Gut: Insights into Microbiota–Nervous System Interactions. Current Issues in Molecular Biology, 47(7), 489. https://doi.org/10.3390/cimb47070489
Vancouver
Savulescu-Fiedler I, Benea SN, Căruntu C, Nancoff AS, Homentcovschi C, Bucurica S. Rewiring the Brain Through the Gut: Insights into Microbiota–Nervous System Interactions. Current Issues in Molecular Biology. 2025;47(7):489. doi:10.3390/cimb47070489
BibTeX
@article{SavulescuFiedler2025,
author = {Savulescu-Fiedler, Ilinca and Benea, Serban-Nicolae and Căruntu, Constantin and Nancoff, Andreea-Simona and Homentcovschi, Corina and Bucurica, Sandica},
title = {Rewiring the Brain Through the Gut: Insights into Microbiota–Nervous System Interactions},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {7},
pages = {489},
doi = {10.3390/cimb47070489}
}
EUVIMED